Health insurer Highmark, based in Pittsburgh, has posted the results of its pay-for-performance program from fiscal year 2011, according to a company news release.
Highmark launched its Quality BLUE pay-for-performance program in 2002 with six hospitals. By fiscal year 2011, program participation grew to 63 hospitals and today includes 81 hospitals.
Major findings include the following:
• Seventy-six percent of female members aged 42-69 received mammography screening for breast cancer from Highmark providers in the past two years — 9 percent more than the national average.
• Seventy-two percent of office-based physicians in the program use electronic prescribing compared to 36 percent nationally.
• An estimated 351 cases of MRSA with a care cost savings estimated between $9.5 million-$12.2 million were eliminated during the past four years of the program.
• An estimated 1,535 central line associated bloodstream infections were eliminated in all nursing units, not just intensive care units, during the last five years, saving potentially 184-384 lives.
Related Articles on Pay-for-Performance:
NYU Langone Strikes Pay-For-Performance Deal With BlueCross BlueShield
Pittsburgh’s West Penn Allegheny, UPMC Shift From Traditional Payment Models
Pay-for-Performance Failed to Find Racial, Ethnic Disparities in Mass. Medicaid
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
